Screener
Eligibility screening
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors
8 US sites in CA, CT, FL, NJ +3
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.